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ABSTRACT 24 
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiological agent for Kaposi’s sarcoma 25 
(KS). Both KSHV and KS are endemic in sub-Saharan Africa where approximately 84% of 26 
global KS cases occur. Nevertheless, whole-genome sequencing of KSHV has only been 27 
completed using isolates from Western countries—where KS is not endemic. The lack of whole-28 
genome KSHV sequence data from the most clinically important geographical region, sub-29 
Saharan Africa, represents an important gap as it remains unclear whether genomic diversity has 30 
a role on KSHV pathogenesis. We hypothesized that distinct KSHV genotypes might be present 31 
in sub-Saharan Africa compared to Western countries. Using a KSHV-targeted enrichment 32 
protocol followed by Illumina deep-sequencing, we generated and analyzed sixteen unique 33 
Zambian, KS-derived, KSHV genomes. We enriched KSHV DNA over cellular DNA 1,851 to 34 
18,235-fold. Enrichment provided coverage levels up to 24,740-fold; therefore, supporting 35 
highly confident polymorphism analysis. Multiple alignment of the sixteen newly sequenced 36 
KSHV genomes showed low level variability across the entire central conserved region. This 37 
variability resulted in distinct phylogenetic clustering between Zambian KSHV genomic 38 
sequences and those derived from Western countries. Importantly, the phylogenetic segregation 39 
of Zambian from Western sequences occurred irrespective of inclusion of the highly variable 40 
genes K1 and K15. We also show that four genes within the more conserved region of the KSHV 41 
genome contained polymorphisms that partially, but not fully, contributed to the unique Zambian 42 
KSHV whole-genome phylogenetic structure. Taken together, our data suggest that the whole 43 
KSHV genome should be taken into consideration for accurate viral characterization.  44 
 45 
 46 
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IMPORTANCE 47 
Our results represent the largest number of KSHV whole-genomic sequences published to date 48 
and the first time that multiple genomes have been sequenced from sub-Saharan Africa, a 49 
geographic area where KS is highly endemic. Based on our new sequence data, it is apparent that 50 
whole-genome KSHV diversity is greater than previously appreciated and differential 51 
phylogenetic clustering exists between viral genomes of Zambia and Western countries. 52 
Furthermore, individual genes may be insufficient for KSHV genetic characterization. Continued 53 
investigation of the KSHV genetic landscape is necessary in order to effectively understand the 54 
role of viral evolution and sequence diversity on KSHV gene functions and pathogenesis. 55 
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INTRODUCTION 56 
Kaposi’s sarcoma-associated herpesvirus (KSHV), or human herpesvirus-8 (HHV-8), is the 57 
etiologic agent for all forms of Kaposi’s sarcoma (KS) (1). KS manifests as an endothelial tumor 58 
primarily on the skin but can also involve mucosal membranes and visceral organs. Among the 59 
HIV-uninfected population KS is rare worldwide; however, HIV infection and 60 
immunosuppression greatly increase the risk of developing KS (2). In sub-Saharan Africa, HIV 61 
is epidemic and KSHV is endemic. Accordingly, KS is one of the most common cancers in sub-62 
Saharan Africa and this region accounts for 84% of global KS cases (3). Two other HIV-63 
associated lymphoproliferative malignancies (primary effusion lymphoma [PEL] and 64 
multicentric Castleman’s disease [MCD]), as well as the KSHV inflammatory cytokine 65 
syndrome (KICS) are also associated with KSHV infection (4-6). However, the role of KSHV 66 
genetic variation on pathogenesis and disease presentation is unknown. Therefore, as a first step, 67 
it is necessary to analyze KSHV genetic variation in sub-Saharan Africa at the whole-genome 68 
level. 69 
 70 
KSHV is a human gamma-herpesvirus with a largely conserved double-stranded DNA genome 71 
of approximately 140 kilobases. However, the extreme 5’ and 3’ termini are disproportionately 72 
variable compared to the central region of the KSHV genome and both have been used to 73 
categorize KSHV into different genotypes (7, 8) The 5’ end encodes the K1 gene and can be 74 
separated into five distinct genotypes (A, B, C, D, E), differing by up to 30% at the amino acid 75 
level. At the nucleotide level, 85% of polymorphisms within K1 are nonsynonymous, suggesting 76 
that strong selective pressure acts on the gene (7). The 3’ terminus of the KSHV genome encodes 77 
the K15 gene. Sequence analysis of K15 supports additional categorization of KSHV sequences 78 
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into P, M, or N alleles, with up to 70% inter-allele divergence at the amino acid level (8, 9). In 79 
addition, nine discrete loci (≈5.6% of the genome) within the central, more conserved, region of 80 
the KSHV genome also contain polymorphisms, albeit at a much lower rate. Together, twelve 81 
KSHV genotypes have been proposed based on these 11 discrete loci (9). However, the 82 
remaining KSHV genes, representing more than 90% of the genome, have not been used to 83 
further characterize KSHV genetic structure and diversity due to a lack of high coverage, whole-84 
genome, viral sequences. 85 
 86 
Presently, only six KSHV whole-genome sequences are available. The first complete, and most 87 
extensively annotated genome, GK18, was generated from a classic KS lesion from a Greek 88 
patient (AF148805.2) (10). The nearly complete, ‘KS’ genome was sequenced using shotgun 89 
sequencing of fragments obtained after Sau3A digestion of DNA from AIDS-associated KS 90 
biopsies (U93872.2) (11). Additionally, three genomic KSHV sequences were generated from 91 
KSHV-infected PEL cell lines, BC-1 (U75698.1), JSC-1 (GQ994935.1), and BCBL-1 92 
(HQ404500.1) (12-14). The sixth and most recently sequenced KSHV genome, DG-1 93 
(JQ619843.1), was the first to be completed using Illumina next-generation sequencing 94 
technology and the first obtained from virus in patient plasma (15). Despite these significant 95 
efforts, all current genomic KSHV sequences were generated from samples obtained in Western 96 
countries where KSHV is not endemic. The lack of whole-genome KSHV sequence data from 97 
sub-Saharan Africa—the geographical region most relevant to KSHV infection—represents an 98 
important gap in genetic characterization for this pathogen as it remains unclear whether a 99 
correlation exists between whole-genome sequence diversity and KSHV pathogenesis. A recent 100 
study of Epstein Barr Virus (EBV) whole genomes revealed significant levels of sequence 101 
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diversity in isolates from nasopharyngeal carcinoma (NPC) clinical samples in a region with 102 
high NPC prevalence (16). This further suggests that a thorough characterization of KSHV 103 
whole-genomes needs to be conducted—including isolates from sub-Saharan Africa— as a first 104 
step to investigate possible relationships between genomic diversity and pathogenesis.  105 
 106 
In the current study, we sought to test the hypothesis that distinct whole-genome KSHV variants 107 
are present in sub-Saharan Africa compared to Western countries. We also investigated whether 108 
diversity within the central region genes may contribute to viral characterization. To this end, we 109 
generated and analyzed KSHV whole-genome sequences derived from KS skin lesions of sixteen 110 
different Zambian patients. Using a biotinylated RNA-library as bait, KSHV sequences were 111 
preferentially enriched over human genomic DNA present in tumor samples and the KSHV-112 
enriched DNA was sequenced using Illumina deep-sequencing technology. Polymorphism and 113 
phylogenetic analyses were then performed to measure KSHV genome-wide diversity. Our 114 
results represent the largest number of KSHV whole-genomic sequences published to date and 115 
the first time that multiple genomes have been sequenced from sub-Saharan Africa, a geographic 116 
area where KS is highly endemic. 117 
 118 
METHODS 119 
KS sample collection. KS biopsies were obtained from patients upon disease presentation at the 120 
skin clinic of the University of Zambia, University Teaching Hospital. The biopsies were 121 
collected as part of KS diagnosis and residual tissue samples were used for the current study. All 122 
patients provided written, informed consent to participate in the study. Collection of biopsies was 123 
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approved by the Institutional Review Board of the University of Nebraska and the University of 124 
Zambia Biomedical Research Ethics Committee. 125 
 126 
Sample DNA preparation. Total DNA was extracted from frozen KS tumor biopsies using the 127 
Gentra Puregene Tissue Kit according to manufacturer’s protocol (Qiagen). Purified DNA 128 
samples were analyzed via Qubit broad-range dsDNA kit, Nanodrop spectrometer, and agarose 129 
gel electrophoresis to measure concentration, protein contamination, and level of degradation. 130 
All samples were of high quality and usable for downstream applications. 131 
 132 
KSHV viral load. The number of KSHV genomes in each KS biopsy sample was quantified 133 
before enrichment using the Bio-Rad QX100 droplet digital PCR (ddPCR) system. Human β-134 
globin and KSHV ORF26 were amplified using primers and probes described previously (17). 135 
Each 20μL ddPCR reaction contained 1X ddPCR Supermix (Bio-Rad), 900nM forward and 136 
reverse primer, 250nM Taqman probe, and 6 or 60ng of genomic DNA. Droplet generation, 137 
amplification, and reading were carried out according to the manufacturer’s protocol. 138 
Amplification conditions for β-globin were as follows: 95°C for 10 min, 40 cycles of 94°C for 30 139 
sec and 60°C for 60 sec, and 98°C for 10 min. KSHV ORF26 amplification conditions were 140 
similar with the exception of a 55°C elongation temperature. All samples were run in triplicate 141 
and the mean KSHV copy number per cellular equivalent was calculated. 142 
 143 
Library preparation, Target Enrichment, and Illumina sequencing. Sample library 144 
preparation and target enrichment were performed using the SureSelectXT Target Enrichment 145 
System (Agilent) according to the manufacturer’s Illumina paired-end sequencing library 146 
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protocol. Briefly, 120bp overlapping RNA baits were custom designed at 5x coverage in 147 
conjunction with Agilent SureDesign based on the KSHV GK18 sequence (AF148805.2). Baits 148 
with high homology to human DNA were excluded from the RNA-library. For each sample, 3μg 149 
of purified KS tissue biopsy DNA was sheared and Illumina specific adapters were added. The 150 
DNA-libraries were then hybridized for KSHV-specific enrichment, index tagged, and pooled at 151 
equimolar amounts for sequencing. Next-generation sequencing was performed using an 152 
Illumina HiSeq with 100bp paired-end reads on two separate runs at the University of Nebraska 153 
DNA Sequencing Core. 154 
 155 
Guided assembly of KSHV genomes. Output reads from the Illumina HiSeq 2500 were filtered 156 
using Trimmomatic (18). Reads were trimmed on both on both 5’ and 3’ extremities using a 157 
quality (Q) threshold keeping only bases with Q>=30. All reads shorter than 101bp long were 158 
filtered out, thus retaining only full-size reads of high quality. The dataset was controlled for 159 
quality using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), both before 160 
and after the filtering steps. 161 
 162 
High quality paired-end reads were aligned to the KSHV genome (GK18, accession: 163 
AF148805.2) using Bowtie2 version 2.2.1 (19). First, reads were assembled one sample at a time 164 
using the Columbus extension of Velvet 1.2.10 (20) and the corresponding initial alignment. A 165 
k-mer size of 91 was found to produce the best results after multiple trials of different values. 166 
Both average and minimum k-mer coverage were determined on a sample-by-sample basis by 167 
first performing a ‘blank’ assembly with the ‘exp_cov’ and ‘cov_cutoff’ parameters set on ‘auto’ 168 
and then looking at the k-mer coverage of the largest contigs produced matching the reference 169 
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sequence. Afterwards, the ‘cov_cutoff’ parameter was set on a tenth of the ‘exp_cov’ value for 170 
the final Velvet assembly. Next, a second assembly was produced for each sample using MIRA 171 
(21) for correction purposes. The same reference sequence, mapping, and accurate flags were 172 
described for Velvet assembly, and lossless digital normalization (-ldn) was activated to reduce 173 
the dataset to a memory-manageable size. 174 
 175 
Correction, scaffolding and annotation. The viral contigs in both assemblies were selected and 176 
ordered by aligning them to the reference sequence using Mauve (22). We also manually merged 177 
neighbor contigs in the Velvet assemblies exhibiting a 10 to 90nt long overlap with each other. 178 
For each sample, a multiple alignment comprising the GK18 reference sequence, the Velvet 179 
assembly, and the MIRA assembly was performed using Kalign2 (23). To generate the final 180 
sequences, conserved regions between the Velvet and MIRA assemblies were accepted and the 181 
discrepancies were manually corrected by comparing the original read alignments to input 182 
sequences. Gap regions were left as strings of NNNs when none of the assemblies could resolve 183 
them. We then used Tablet (24) and Jalview (25) for visualization of reads and genome 184 
alignment respectively. 185 
 186 
After determining the final assembly, each new genome was annotated. Given the close 187 
proximity to the KSHV reference sequence, the annotation of each new genome was carried out 188 
by transferring the available KHSV annotation in Genbank using RATT (26). However, splicing 189 
junctions were unsuccessfully transferred for the K8 and K15 genes. Manual correction was 190 
therefore performed for both genes because the K8 exons/introns annotated in the GK18 191 
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Genbank entry do not accurately reflect previously reported splicing (27), and the K15 gene 192 
features many exons that RATT could not transfer. 193 
 194 
Accession numbers. The final consensus sequence of each sample, and it’s annotation, can be 195 
found at the following accession numbers : KT271453 (ZM004), KT271454 (ZM027), 196 
KT271455 (ZM091), KT271456 (ZM095), KT271457 (ZM102), KT271458 (ZM106), 197 
KT271459 (ZM108), KT271460 (ZM114), KT271461 (ZM116), KT271462 (ZM117), 198 
KT271463 (ZM118), KT271464 (ZM121), KT271465 (ZM123), KT271466 (ZM124), 199 
KT271467 (ZM128), KT271468 (ZM130). 200 
 201 
Comparative and phylogenetic sequence analysis. The assembled KSHV genomes were 202 
aligned using Kalign2. The multiple alignment was then used to generate whole-genome 203 
maximum likelihood phylogenetic trees using PhyML (28) with 1000 bootstrap replicates, and 204 
the trees were visualized using MEGA6 (29).  Genome-wide mutations were visualized using the 205 
mVista software (30), with a 100bp scanning window. Multiple amino acid alignments were 206 
generated for each KSHV gene and inspected for high level of nonsynonymous mutations. 207 
Maximum likelihood phylogenetic trees were generated using PhyML and amino acid 208 
highlighter plots were generated to visualize the specific mutations using the Highlighter tool as 209 
part of the Los Alamos National Laboratory HIV sequence database (www.hiv.lanl.gov). 210 
Reference sequences used for K1 genotyping were as follows: AF133038 (A1), AF130305 (A2), 211 
U86667 (A3), AF133039 (A4), AF178823 (A5), AF133040 (B1), AY042947 (B2), AY042941 212 
(B3), DQ309754 (B4), AF133041, (C1), AF133042 (C3), AF133043 (D1), AF133044 (D2), and 213 
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AF220292 (E). Reference sequences used for K15 classification were AAD46505.1 (P), 214 
AAD45296.1 (M), and a personal communication from Gary Howard (N). 215 
 216 
RESULTS 217 
Summary of sequencing data. In the present study, we analyzed the sequence diversity of 218 
KSHV whole genomes acquired from KS skin biopsies of sixteen Zambian patients—11 males 219 
and 5 females. Clinical data collected for each patient is summarized in Table 1. Total DNA was 220 
extracted from the biopsy samples and KSHV burden in tumor tissue ranged from 0.21 to 17.16 221 
copies per cell (Table 2). In order to efficiently sequence the KSHV DNA, which was present as 222 
a small proportion of total tumor DNA (0.0006% - 0.05%), we used a custom biotinylated RNA-223 
library (Agilent) to hybridize and selectively enrich the KSHV DNA for sequencing with an 224 
Illumina HiSeq.  225 
 226 
We first tested the efficiency of our whole protocol, from DNA enrichment to genome 227 
sequencing, on three samples (ZM116, ZM117, and ZM118). This process resulted in up to 228 
12,107-fold enrichment of KSHV DNA over cellular DNA with 62% of the total sequence reads 229 
mapped to the KSHV reference sequence (GK18). The GK18 sequence was selected because it is 230 
currently the most comprehensively annotated KSHV sequence and also served as the reference 231 
for generating the RNA bait library employed in the current study. After our initial results, we 232 
continued with the remaining 13 samples in a second run of DNA enrichment and deep-233 
sequencing. A total of 528,849,840 paired-end reads, 101bp long, were produced from both 234 
HiSeq runs with an average of 49% of the sequence reads mapped to KSHV. Together, we 235 
obtained a mean enrichment of KSHV DNA over cellular DNA of 8,437-fold (range 1,851 - 236 
12 
 
 
 
18,235-fold) (Table 2). Thus, we were able to filter the dataset at a high quality threshold and 237 
still maintain high depth of coverage (mean: 8,437-fold; range: 786 - 24,740-fold) (Table 2). 238 
 239 
The assembly of each viral genome was conducted in a two-step approach: first the sequence 240 
reads were assembled using Velvet and the KSHV reference sequence; then this initial assembly 241 
was manually corrected with the help of a second assembly generate using MIRA. After manual 242 
fusion of contigs exhibiting large overlaps in the initial Velvet assembly, each genome featured 243 
an average of 4 contigs. This is consistent with the presence of 3 major repeat regions in KHSV 244 
that were hard to resolve using short-read sequencing technology alone. After manual correction 245 
with the MIRA assembly, we were able to reduce this value to an average of 2 contigs per 246 
genome. All genomes were correctly sized with an average of 137Kb, corresponding to the size 247 
of previously published KSHV genomes from Western sources. Apart from the repeat regions, 248 
most genomes (12 of 16) had uniform read coverage. However, four genomes (ZM091, ZM095, 249 
ZM116, and ZM124) showed a few regions with coverage of up to 3 times the sample average. 250 
Nevertheless, these discrepancies did not hinder the assembly process. 251 
 252 
KSHV whole-genome variability analysis. The sixteen newly assembled and annotated KSHV 253 
genomic sequences, in addition to the six previously sequenced KSHV genomes, were used for 254 
multiple alignment and analyzed phylogenetically. Gaps and/or repeated regions of each 255 
genome, including the reference sequence, were masked. Figure 1 presents an unrooted 256 
maximum likelihood tree depicting the relative phylogenetic distance between samples. 257 
Although the overall identity at the nucleotide level is very high among the 22 genomes 258 
(Supplemental Figure 1), distinct phylogenetic clusters are evident. All previously published 259 
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KSHV genomes from Western countries clustered together, while the isolates from Zambia 260 
appear to form two separate clusters and contain much more variability among isolates. Isolate 261 
ZM004 diverged substantially from all other sequences and therefore was used to root 262 
subsequent whole-genome cladograms. The distinct phylogenetic clusters with higher variability 263 
among Zambian isolates can also be seen in the ZM004-rooted cladogram (Figure 2A).  264 
 265 
The K1 and K15 genes are known to vary greatly among KSHV isolates and K1 subtypes are 266 
associated with specific geographical regions. Therefore, we investigated whether variability in 267 
K1 or K15 correlated with the KSHV-whole genome variability we detected. To this end, we 268 
performed a multiple alignment of all 22 KSHV genomic sequences without the K1 or K15 269 
genes and generated a ZM004-rooted cladogram. Despite removing the highly variable genes, 270 
the topology of the phylogenetic tree remained similar to that of the whole-genome KSHV 271 
cladogram (Figures 2A and 2B). The only difference was a slight restructuring among the 272 
Western isolates, most likely because the BC-1 isolate contains the K15 M allele. Moreover, 273 
when nucleotide phylogenetic trees were generated from the K1 and K15 sequences, the tree 274 
topology and sample clustering did not correlate with the whole-genome phylogenetic analysis 275 
(Figures 2C and 2D). Together this indicates that the phylogenetic clustering detected at the 276 
whole-genome level is a function of variability in the central region of the KSHV genome. 277 
 278 
We then sought to investigate whether variability in the central region of the Zambian KSHV 279 
isolates could be accurately characterized by individual genes or if consideration of the whole 280 
region is required. The distribution of nucleotide variability among the central region of all 22 281 
KSHV genomes compared to GK18 was visualized using mVista (Figure 3). We did not find any 282 
14 
 
 
 
areas of high nucleotide variation, other than the K1 and K15 genes; rather, we detected low-283 
level variation throughout the entire central region when the Zambian isolates were compared to 284 
GK18 (Figure 3).   285 
 286 
The total number of mutations compared to the GK18 sequence, including deletions, insertions, 287 
and substitutions, for each of the sixteen Zambian KSHV genomes is summarized in Table 2. We 288 
did not identify any correlations between the Zambian KSHV isolate sequence variation and 289 
clinical data. Additionally, we did not detect any intra-subject sequence variation, indicating that 290 
KSHV within each KS tumor was clonal. 291 
 292 
KSHV coding region mutations. Given that the phylogenetic segregation between Western and 293 
Zambian KSHV genomic sequences was due to low level variation across the central region of 294 
the genome, we inspected all coding sequences for nonsynonymous mutations compared to the 295 
GK18 reference genome. Out of the 84 annotated coding regions, we identified six KSHV genes 296 
with high levels of nonsynonymous mutations—four within the central conserved region (K4.2, 297 
K8.1, K11/vIRF2, and K12/Kaposin) and two previously known to have high variability (K1 and 298 
K15). Among the genes within the central region of the KSHV genome, K4.2 contained the 299 
highest level of nonsynonymous mutations compared GK18. Phylogenetic analysis of the K4.2 300 
gene revealed similar clusters for samples ZM004, ZM114, and ZM130 compared to the whole-301 
genome analysis, but not for the remaining samples (Figure 4A).  ZM091, ZM095, and ZM118 302 
were very similar to GK18, with only three amino acid substitutions, whereas the remaining 303 
K4.2 sequences contained more than 20 substitutions and/or significant truncations at the C-304 
terminal end of the coding region (Figure 4B). Sample ZM124 contained a 25 nucleotide 305 
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deletion in the K8.1 coding sequence resulting in a frameshift mutation that produced a stop 306 
codon very early in the gene (Figure 5B). Additionally, multiple amino acid substitutions, 307 
insertions, and deletions were identified within the K11/vIRF2 and K12/Kaposin genes (Figures 308 
5C and 5D). 309 
 310 
Since K1 and K15 have previously been demonstrated to be highly variable and are frequently 311 
used for KSHV genotyping, we generated amino acid maximum likelihood phylogenetic trees, 312 
including reference sequences, to determine the K1 and K15 genotypes of the sixteen Zambian 313 
KSHV isolates (Figure 6). All K1 sequences clustered with genotypes A5 (n = 1) or B (n = 15), 314 
consistent with previous K1 genotyping of samples from Zambia (17). Within the B genotype, 315 
nine samples clustered with the sub-genotype B1, two with B3, and four with B4. The majority 316 
of the Zambian KSHV isolates contained the K15 P allele, however, two isolates (ZM095 and 317 
ZM128) contained the rare N allele. This is the first time the K15 N allele has been identified in 318 
Zambia. 319 
 320 
DISCUSSION 321 
Exploring relationships between KSHV sequence polymorphism and disease pathogenesis 322 
requires a more complete perspective of the magnitude and breadth of viral sequence diversity in 323 
geographical regions with the highest KSHV disease prevalence. However, little is known 324 
regarding the whole-genome diversity of KSHV, as only six complete genomes have been 325 
sequenced. Moreover, none of those previously published KSHV genomic sequences derive 326 
from sub-Saharan Africa—where prevalence of KSHV and KS is the highest. In the current 327 
study, we report the enrichment, sequencing, assembly, and analysis of sixteen unique Zambian 328 
16 
 
 
 
KSHV genomes isolated from KS tumors in adults. This study is the first to utilize SureSelect 329 
target capture technology to enrich and sequence KSHV DNA from clinical KS biopsies. Using 330 
this approach we were able to efficiently enrich and sequence KSHV from all KS tumor biopsy DNA 331 
available, including a sample with KSHV viral burden of only 0.21 copies per cell, to obtain enough 332 
depth of coverage for sequence analyses. The data generated represents the largest number of KSHV 333 
whole-genomic sequences published to date. Additionally, this study is the first to compare 334 
multiple KSHV genomes from a common geographical region that is endemic for KS.  335 
 336 
Due to the low ratio of KSHV:human DNA in each tumor preparation, targeted enrichment of 337 
KSHV DNA was required prior to Illumina deep-sequencing. The enrichment protocol we 338 
employed resulted in 1,851 - 18,235-fold KSHV enrichment. This supported an average 339 
coverage depth of 8,437-fold, therefore, allowing high confidence in downstream polymorphism 340 
analyses. To further improve the accuracy of our whole-genome assemblies, we used MIRA 341 
assembly software to corroborate the Velvet-generated assemblies for each genome. Despite its 342 
overall accuracy, Velvet still produced a few clearly misassembled regions or unjustified gaps. 343 
Therefore, the two-step assembly enabled us to capitalize on Velvet’s accuracy while correcting 344 
nearly all misassembled regions and gaps with MIRA. 345 
 346 
Given the extremely low error-rate of herpesvirus polymerases (31), it is not surprising that 347 
previous comparisons of the six KSHV whole-genomes revealed a high level of sequence 348 
conservation (15). The genomic conservation might also be anticipated because the sequences 349 
were all generated from US or European patient samples, despite derivation from distinct clinical 350 
presentations. Multiple alignment of the sixteen newly sequenced Zambian KSHV genomes also 351 
showed high conservation. However, a low level variability across the central conserved region 352 
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resulted in distinct phylogenetic clustering between the genomic sequences of Zambian KSHV 353 
isolates and those from Western countries.  354 
 355 
For EBV, the divergent EBNA-3 alleles correlate with whole-genome clustering and serve as 356 
adequate surrogates to distinguish between EBV type-1 and -2 (16, 32), but this has not 357 
previously been investigated for KSHV. The genes at either termini of the KSHV genome, K1 358 
and K15, have been previously shown to contain higher levels of polymorphism than the rest of 359 
the genome. Our Zambian KSHV sequence data also revealed high levels of sequence diversity 360 
at these loci. Nevertheless, when K1 and K15 were excluded from the whole-genome multiple 361 
alignment and subsequent phylogenetic analysis the topology of the phylogenetic tree did not 362 
change. Moreover, the topology of the KSHV whole-genome phylogenetic tree did not correlate 363 
with those of phylogenetic trees generated from K1 or K15 alone, suggesting that these genes are 364 
poor surrogates for measuring whole-genome KSHV diversity. Conversely, K4.2 phylogenetic 365 
analysis showed partial, but not full, correlation to whole-genomic clustering. This suggests that 366 
K4.2 may contribute to viral genomic characterization, but again, this single gene does not 367 
adequately characterize the whole-genome diversity we detected. Taken together, our data 368 
suggest that the whole KSHV genome should be taken into consideration for accurate viral 369 
characterization. 370 
 371 
Although single gene polymorphisms did not adequately represent the genome-wide KSHV 372 
diversity, we identified several nonsynonymous mutations within KSHV protein coding regions 373 
that could potentially affect the viral phenotype. Interestingly, all six genes with significant 374 
levels of nonsynonymous mutations were gene products uniquely encoded by KSHV. Five of the 375 
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variant genes identified in this study are directly immunomodulatory genes and therefore, may 376 
lead to differential effects on the host immune response. Of interest, the coding sequences of 377 
K4.2 contained the highest level of nonsynonymous variation. K4.2 interacts with pERP1 to 378 
inhibit immunoglobulin secretion and increase calcium influx (33). The amino acid domains of 379 
K4.2 that are important for these functions are unknown, hence the newly identified variability 380 
may be important for interaction with pERP1 or other cellular functions. This is currently under 381 
investigation.  382 
 383 
K8.1 protein is not known to be directly immunomodulatory, but this virion membrane-384 
associated glycoprotein does have important effects on the KSHV viral life cycle. K8.1 is 385 
utilized for KSHV attachment to target cells and induces VEGF expression upon binding (34, 386 
35). Additionally, while K8.1 is necessary for efficient virus egress from infected cells, a K8.1-387 
null mutant virus can still infect HEK293 cells, indicating that K8.1 function may be dispensable 388 
for virus entry in vitro (35, 36).  The nucleotide sequence from sample ZM124 predicted a 389 
truncation in the amino acid sequence before the transmembrane domain of K8.1. If the protein 390 
were expressed as predicted, it is not clear what effect a K8.1-deficient virion and/or virion-391 
independent, soluble K8.1 would have in the context of an in-vivo infection. K8.1 is highly 392 
immunogenic compared to other KSHV proteins (37), and exogenous expression of soluble K8.1 393 
induces an interferon response (38). Together, the ZM124 predicted K8.1 may elicit a modified 394 
innate and humoral immune response. 395 
 396 
Among the 16 newly sequenced KSHV genomes one isolate, ZM091, contained an A5 K1 gene. 397 
The A genotype is primarily found in Europe, while the B genotype is found only in sub-Saharan 398 
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Africa; therefore, previous analyses of KSHV molecular evolution have suggested that the A5 399 
genotype arose in sub-Saharan Africa as a result of recombination. While we cannot exclude the 400 
possibility of this hypothesis, the sequence data obtained in the present study does not provide 401 
evidence of chimeric boundaries near the 5’ terminus. 402 
 403 
Three primary K15 alleles have been previously identified, P, M, and N. There is little variation 404 
within allele groups but extreme divergence across alleles. The P and M alleles, for example, 405 
have only 30% identity (8). We identified, for the first time, two KSHV isolates from Zambia 406 
that contain the rare K15 N allele. Although the N allele is highly divergent from P and M, the 407 
signaling motifs for SH2 and TRAF are conserved in all K15 alleles. Recently, it was shown that 408 
the K15-P allele activates the alternative NF-κB signaling pathway by direct recruitment of NF-409 
κB inducing kinase (NIK) to a distinct signal sequence (39). However, this sequence is not 410 
conserved in either the M or N alleles. This genetic variation may lead to altered levels of K15-411 
induced NF-κB activation and subsequently functional differences between alleles, thus further 412 
functional analyses of these K15 alleles is warranted. 413 
 414 
In summary, we successfully enriched KSHV from a background of human DNA from KS 415 
biopsies using targeted RNA baits. Analyses of the sequences identified a low level variability 416 
across the KSHV central conserved region that resulted in distinct phylogenetic clustering 417 
between the genomic sequences of KSHV from Zambia and Western countries. Moreover, four 418 
genes within this region had significant levels of polymorphisms but did not adequately 419 
characterize the whole-genome diversity we detected. Based on the new sequence data in the 420 
present study, it is apparent that whole-genome KSHV diversity is greater than previously 421 
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appreciated. Although the observed phylogenetic clustering between Western and Zambian 422 
KSHV genomic sequences could represent distinct subtypes, more whole-genome sequences are 423 
required from additional regions to infer distinct viral subtypes specific to any geographical 424 
region. Continued investigation of the KSHV genetic landscape is necessary in order to 425 
effectively understand the role of viral evolution and sequence diversity on KSHV gene 426 
functions and pathogenesis.  427 
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FIGURE LEGENDS 564 
Figure 1. Unrooted nucleotide maximum likelihood phylogenetic tree of six previously 565 
published KSHV whole-genome sequences and 16 new KSHV whole-genome sequences from 566 
Zambian KS biopsies. Phylogenetic tree was generated using PhyML with 1000 bootstrap 567 
replicates and visualized using MEGA6. 568 
 569 
Figure 2. Maximum likelihood phylogenetic tree analysis of 22 KSHV whole genomes and 570 
nucleotide sequence of K1 and K15 genes. All phylogenetic trees were generated using PhyML 571 
with 1000 bootstrap replicates and visualized using MEGA6. (A) KSHV whole genome 572 
cladogram rooted on sample ZM004. (B) ZM004-rooted cladogram of KSHV whole genome 573 
with K1 and K15 gene sequences removed. (C and D) Midpoint-rooted cladogram of KSHV K1 574 
(C) and K15 (D) sequences from 22 KSHV whole genome sequences. 575 
  576 
Figure 3. Distribution of nucleotide variation within the central region of the KSHV genome as 577 
compared to the reference sequence GK18. The figure was generated using mVista software with 578 
a 100bp scanning window. The curve for each sequence represents up to 10% nucleotide 579 
variation within that window. Topological phylogenetic tree of sequences was generated using 580 
PhyML and visualized using MEGA6. Of note, multiple regions within the DG-1 sequence 581 
appear to have significant nucleotide diversity compared to GK18; however, these regions 582 
represent gaps in the published sequence due to low coverage that could not be masked. 583 
 584 
Figure 4. Amino acid polymorphisms within the K4.2 gene. (A) Maximum likelihood 585 
phylogenetic tree of K4.2 amino acid sequence generated using PhyML with 1000 bootstrap 586 
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replicates and visualized using MEGA6. (B) Amino acid highlighter plot of K4.2 generated 587 
using the Highlighter tool as part of the Los Alamos National Laboratory HIV sequence 588 
database. 589 
 590 
Figure 5. Amino acid polymorphisms of three other KSHV central region genes. (A) Amino acid 591 
highlighter plot coloring scheme. Amino acid highlighter plots were generated for KSHV genes 592 
K8.1 (B), vIRF-2 (C), and K12 (D) using the Highlighter tool as part of the Los Alamos National 593 
Laboratory HIV sequence database. 594 
 595 
Figure 6. KSHV K1 and K15 subtyping. Phylogenetic analyses using amino acid sequences for 596 
K1 (A) and K15 (B) from the 22 KSHV genomic sequences and prototypic reference sequences. 597 
Maximum likelihood phylogenetic trees were generated using PhyML with 1000 bootstrap 598 
replicates and visualized using MEGA6. 599 
  600 
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Table 1. Clinical information for 16 KS patients.
Patient ID Gender Age HIV Status ART Status
ZM004 F 35 + + 
ZM027 F 15 + - 
ZM091 M 30 + + 
ZM095 M 41 + + 
ZM102 F 45 + N/A 
ZM106 M 36 + + 
ZM108 M 33 + + 
ZM114 F 29 + N/A 
ZM116 F 42 N/A N/A 
ZM117 M 34 + N/A 
ZM118 M 29 N/A N/A 
ZM121 M 37 + + 
ZM123 M 30 + + 
ZM124 M 25 N/A N/A 
ZM128 M 32 + - 
ZM130 M 33 + - 
N/A, Not available. 
 601 
  602 
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Table 2. Summary of data from sequencing analysis.
Patient ID 
KHSV Genome 
Size (bp) 
Depth of  
Coverage 
Total 
mutations Insertions Deletions Substitutions
KSHV copies per 
cell 
in biopsy DNA
KSHV:Human 
DNA 
Before Enrichment
KSHV:Human 
DNA 
After Enrichment
Fold 
Increase
ZM004 136,691 4,507 1344 63 58 1223 1.43 0.0038% 38.43% 10,184 
ZM027 137,054 9,160 1289 63 61 1165 5.51 0.0146% 66.50% 4,546 
ZM091 136,919 4,448 1063 53 61 949 0.76 0.0020% 37.03% 18,235 
ZM095 137,610 9,886 1714 104 104 1506 17.16 0.0456% 84.36% 1,851 
ZM102 136,629 8,228 1214 53 68 1093 3.84 0.0102% 59.51% 5,830 
ZM106 137,026 7,570 1032 67 66 899 9.68 0.0257% 67.16% 2,611 
ZM108 136,568 7,758 1196 62 63 1071 2.72 0.0072% 53.72% 7,438 
ZM114 137,071 3,861 1237 61 42 1134 1.4 0.0037% 40.40% 10,841 
ZM116 136,969 24,740 862 39 39 784 1.95 0.0052% 62.75% 12,107 
ZM117 137,143 15,517 1183 55 61 1067 2.07 0.0055% 57.85% 10,541 
ZM118 137,429 19,961 859 58 18 783 ND ND 45.21% ND 
ZM121 137,279 1,023 1250 119 63 1068 ND ND 8.52% ND 
ZM123 136,262 786 1404 423 67 914 0.21 0.0006% 7.08% 12,768 
ZM124 137,457 6,209 911 43 58 810 ND ND 73.84% ND 
ZM128 137,272 6,740 1858 200 89 1569 2.75 0.0073% 51.64% 7,076 
ZM130 136,908 4,603 1259 54 72 1133 1.14 0.0030% 32.74% 10,822 
ND, Not determined. 
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